Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Health

JB Chemicals & Pharmaceuticals Forays Into Nephrology Segment In India

The launch of this division will also enable nephrologists and physicians to provide patients with different treatment options and ultimately improve the quality of life in these patients

Read More

Alembic Pharma Gets USFDA Nod For Ophthalmic Solution

Alembic Pharma said Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2 per cent and 0.5 per cent has an estimated market size of USD 80 million for twelve months ending December 2020.

Read More

Pilots Body Seeks Vaccination Camps For Flying Crew

Alleging that many crew have been tested positive for Covid-19 and are struggling to get oxygen cylinders, the ICPA said that the pilots are left to fend for themselves for hospitalization.

Read More

Alembic Pharma Q4 Net Profit Up 12 % At Rs 251 Cr

Consolidated revenue from operations stood at Rs 1,280.39 crore for the quarter under consideration. It was Rs 1,206.83 crore for the same period a year ago, it added.

Read More

Glenmark Pharma Launches Nasal Spray Ryaltris In India

Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India.

Read More

Dr Reddy's Launches Generic Drug In US Market

The Albenza brand and generics had sales of around USD 27 million in the US for the most recent twelve months ending in November 2020.

Read More

Redefining The ‘Healthy, Wealthy And Wise’

Health and wellness above all is the most important facet of our lives today and life insurers who embrace wellness in their offerings are set to become highly “relevant insurers”.

Read More

Sanofi India Q1 Net Profit At Rs 145.9 Cr

Revenue from operations of the company stood at Rs 725.1 crore for the quarter under consideration. It was Rs 784.5 crore for the same period a year ago

Read More

Remdesivir Production Expected To Start In Wardha From Wednesday

Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and children hospitalised with severe disease.

Read More

Mankind Pharma To Donate Rs 100 Cr To Families Of Deceased Frontline COVID Warriors

As the country continues to grapple with the second wave of coronavirus pandemic, healthcare and frontline workers are racing against time to contain its spread.

Read More

Natco Seeks CDSCO Approval For Phase-III Trial Of Molnupiravir For COVID-19 Treatment

Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of phase-III clinical trial of Molnupiravir capsules for the treatment of COVID-19 positive patients

Read More

Glenmark Pharma To Launch Its Nasal Spray Ryaltris In EU

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age.

Read More

Biocon Biologics, Viatris Receive EC Nod For Biosimilar Bevacizumab

The centralised marketing authorisation granted by the EC is valid in all EU Member States as well as in the European Economic Area countries Iceland, Liechtenstein and Norway

Read More

Lupin, Sun Pharma, Jubilant Cadista Recall Drugs In US Market

The affected lot has been produced by Jubilant Generics at its Roorkee based plant in Uttarakhand and marketed in the US by Salisbury-based Jubilant Cadista Pharmaceuticals, Inc.

Read More

Offered Not-For-Profit Price For COVID Vax; To Supply Through Govt Contracts In India: Pfizer

'For India, Pfizer has offered a not-for-profit price for its vaccine for the government immunization program', it added without revealing the price.

Read More